142 related articles for article (PubMed ID: 29872115)
1. Biochemical mechanisms implemented by human acute myeloid leukemia cells to suppress host immune surveillance.
Yasinska IM; Gonçalves Silva I; Sakhnevych S; Gibbs BF; Raap U; Fasler-Kan E; Sumbayev VV
Cell Mol Immunol; 2018 Nov; 15(11):989-991. PubMed ID: 29872115
[TBL] [Abstract][Full Text] [Related]
2. Tim-3 is highly expressed in T cells in acute myeloid leukemia and associated with clinicopathological prognostic stratification.
Li C; Chen X; Yu X; Zhu Y; Ma C; Xia R; Ma J; Gu C; Ye L; Wu D
Int J Clin Exp Pathol; 2014; 7(10):6880-8. PubMed ID: 25400771
[TBL] [Abstract][Full Text] [Related]
3. Natural killer cell immune escape in acute myeloid leukemia.
Lion E; Willemen Y; Berneman ZN; Van Tendeloo VF; Smits EL
Leukemia; 2012 Sep; 26(9):2019-26. PubMed ID: 22446501
[TBL] [Abstract][Full Text] [Related]
4. The Tim-3-galectin-9 Secretory Pathway is Involved in the Immune Escape of Human Acute Myeloid Leukemia Cells.
Gonçalves Silva I; Yasinska IM; Sakhnevych SS; Fiedler W; Wellbrock J; Bardelli M; Varani L; Hussain R; Siligardi G; Ceccone G; Berger SM; Ushkaryov YA; Gibbs BF; Fasler-Kan E; Sumbayev VV
EBioMedicine; 2017 Aug; 22():44-57. PubMed ID: 28750861
[TBL] [Abstract][Full Text] [Related]
5. Increase in myeloid-derived suppressor cells (MDSCs) associated with minimal residual disease (MRD) detection in adult acute myeloid leukemia.
Sun H; Li Y; Zhang ZF; Ju Y; Li L; Zhang BC; Liu B
Int J Hematol; 2015 Nov; 102(5):579-86. PubMed ID: 26358057
[TBL] [Abstract][Full Text] [Related]
6. [Indoleamine 2, 3-dioxygenase activity in acute myeloid leukemia cells contributing to tumor immune escape].
Tang XQ; Zhao ZG; Wang HX; Li QB; Lü J; Zou P
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Jun; 14(3):539-42. PubMed ID: 16800938
[TBL] [Abstract][Full Text] [Related]
7. [A TIM-3/galectin-9 autocrine stimulatory loop drives self-renewal of human myeloid leukemia stem cells and leukemia progression].
Kikushige Y
Rinsho Ketsueki; 2016 Apr; 57(4):412-6. PubMed ID: 27169443
[TBL] [Abstract][Full Text] [Related]
8. Regulatory T cells-derived IL-35 promotes the growth of adult acute myeloid leukemia blasts.
Tao Q; Pan Y; Wang Y; Wang H; Xiong S; Li Q; Wang J; Tao L; Wang Z; Wu F; Zhang R; Zhai Z
Int J Cancer; 2015 Nov; 137(10):2384-93. PubMed ID: 25866142
[TBL] [Abstract][Full Text] [Related]
9. Differential expression and biochemical activity of the immune receptor Tim-3 in healthy and malignant human myeloid cells.
Gonçalves Silva I; Gibbs BF; Bardelli M; Varani L; Sumbayev VV
Oncotarget; 2015 Oct; 6(32):33823-33. PubMed ID: 26413815
[TBL] [Abstract][Full Text] [Related]
10. LILRB4 signalling in leukaemia cells mediates T cell suppression and tumour infiltration.
Deng M; Gui X; Kim J; Xie L; Chen W; Li Z; He L; Chen Y; Chen H; Luo W; Lu Z; Xie J; Churchill H; Xu Y; Zhou Z; Wu G; Yu C; John S; Hirayasu K; Nguyen N; Liu X; Huang F; Li L; Deng H; Tang H; Sadek AH; Zhang L; Huang T; Zou Y; Chen B; Zhu H; Arase H; Xia N; Jiang Y; Collins R; You MJ; Homsi J; Unni N; Lewis C; Chen GQ; Fu YX; Liao XC; An Z; Zheng J; Zhang N; Zhang CC
Nature; 2018 Oct; 562(7728):605-609. PubMed ID: 30333625
[TBL] [Abstract][Full Text] [Related]
11. Clonal evolution including partial loss of human leukocyte antigen genes favoring extramedullary acute myeloid leukemia relapse after matched related allogeneic hematopoietic stem cell transplantation.
Stölzel F; Hackmann K; Kuithan F; Mohr B; Füssel M; Oelschlägel U; Thiede C; Röllig C; Platzbecker U; Schetelig J; Illmer T; Schaich M; Seliger B; Hartmann A; Baretton G; Zietz C; Ehninger G; Schrock E; Bornhäuser M
Transplantation; 2012 Apr; 93(7):744-9. PubMed ID: 22314337
[TBL] [Abstract][Full Text] [Related]
12. The role of the immunosuppressive microenvironment in acute myeloid leukemia development and treatment.
Isidori A; Salvestrini V; Ciciarello M; Loscocco F; Visani G; Parisi S; Lecciso M; Ocadlikova D; Rossi L; Gabucci E; Clissa C; Curti A
Expert Rev Hematol; 2014 Dec; 7(6):807-18. PubMed ID: 25227702
[TBL] [Abstract][Full Text] [Related]
13. Acute myeloid leukaemia and the immune system: implications for immunotherapy.
Barrett AJ
Br J Haematol; 2020 Jan; 188(1):147-158. PubMed ID: 31782805
[TBL] [Abstract][Full Text] [Related]
14. Hypothesis: Tim-3/galectin-9, a new pathway for leukemia stem cells survival by promoting expansion of myeloid-derived suppressor cells and differentiating into tumor-associated macrophages.
Gao L; Yu S; Zhang X
Cell Biochem Biophys; 2014 Sep; 70(1):273-7. PubMed ID: 24639110
[TBL] [Abstract][Full Text] [Related]
15. [Biological properties and sensitivity to induction therapy of differentiated cells expressing atypical immunophenotype in acute leukemia of children].
Pituch-Noworolska A
Folia Med Cracov; 2001; 42(3):5-80. PubMed ID: 12353422
[TBL] [Abstract][Full Text] [Related]
16. A TIM-3/Gal-9 Autocrine Stimulatory Loop Drives Self-Renewal of Human Myeloid Leukemia Stem Cells and Leukemic Progression.
Kikushige Y; Miyamoto T; Yuda J; Jabbarzadeh-Tabrizi S; Shima T; Takayanagi S; Niiro H; Yurino A; Miyawaki K; Takenaka K; Iwasaki H; Akashi K
Cell Stem Cell; 2015 Sep; 17(3):341-52. PubMed ID: 26279267
[TBL] [Abstract][Full Text] [Related]
17. Acute Myeloid Leukemia Cells Express ICOS Ligand to Promote the Expansion of Regulatory T Cells.
Han Y; Dong Y; Yang Q; Xu W; Jiang S; Yu Z; Yu K; Zhang S
Front Immunol; 2018; 9():2227. PubMed ID: 30319662
[TBL] [Abstract][Full Text] [Related]
18. TIM-3 is a promising target to selectively kill acute myeloid leukemia stem cells.
Kikushige Y; Shima T; Takayanagi S; Urata S; Miyamoto T; Iwasaki H; Takenaka K; Teshima T; Tanaka T; Inagaki Y; Akashi K
Cell Stem Cell; 2010 Dec; 7(6):708-17. PubMed ID: 21112565
[TBL] [Abstract][Full Text] [Related]
19. Selection of Tumor-Specific Cytotoxic T Lymphocytes in Acute Myeloid Leukemia Patients Through the Identification of T-Cells Capable to Establish Stable Interactions With the Leukemic Cells: "Doublet Technology".
García-Guerrero E; Sánchez-Abarca LI; Domingo E; Ramos TL; Bejarano-García JA; Gonzalez-Campos JA; Caballero-Velázquez T; Pérez-Simón JA
Front Immunol; 2018; 9():1971. PubMed ID: 30233577
[TBL] [Abstract][Full Text] [Related]
20. Immune checkpoint molecules in acute myeloid leukaemia: managing the double-edged sword.
Hobo W; Hutten TJA; Schaap NPM; Dolstra H
Br J Haematol; 2018 Apr; 181(1):38-53. PubMed ID: 29318591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]